Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Zimmermann

Showing results (151-160 of 279) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNSGunnar Cario, Shai Izraeli, Anja Teichert, et al.
Blood Advances|July 1, 2018
Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 studyMarius Flasinski, Kira Scheibke, Martin Zimmermann, et al.
British Journal of Haematology|February 24, 2026
Invasive yeast infection in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009Andreas H Groll, Simone Cesaro, Julia Alten, et al.
Haematologica|February 19, 2011
The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97)Gabriele Escherich, Anja Tröger, Ulrich Göbel, et al.
The Journal of Experimental Medicine|October 2, 2013
Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemiaLena Harder, Georg Eschenburg, Antonia Zech, et al.
Haematologica|June 6, 2020
Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemiaMarketa Zaliova, Eliska Potuckova, Julius Lukes, et al.
Leukemia|October 16, 2019
Treatment and outcome of IG-MYC<sup>+</sup> neoplasms with precursor B-cell phenotype in childhood and adolescenceHeidi Herbrueggen, Stephanie Mueller, Jonas Rohde, et al.
Therapeutic Drug Monitoring|December 7, 2017
Therapeutic Drug Monitoring of Asparaginase Activity-Method Comparison of MAAT and AHA Test Used in the International AIEOP-BFM ALL 2009 TrialClaudia Lanvers-Kaminsky, Andrea Rüffer, Gudrun Würthwein, et al.
Leukemia|June 6, 2024
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, et al.
HNO|January 12, 2024
Combination of nivolumab with standard induction chemotherapy in children and adults with EBV-positive nasopharyngeal carcinoma : Protocol of a prospective multicenter phase 2 trialTristan Römer, Christian Vokuhl, Gundula Staatz, et al.
Pageof 28

Showing results (151-160 of 279) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNSGunnar Cario, Shai Izraeli, Anja Teichert, et al.
Blood Advances|July 1, 2018
Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 studyMarius Flasinski, Kira Scheibke, Martin Zimmermann, et al.
British Journal of Haematology|February 24, 2026
Invasive yeast infection in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009Andreas H Groll, Simone Cesaro, Julia Alten, et al.
Haematologica|February 19, 2011
The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97)Gabriele Escherich, Anja Tröger, Ulrich Göbel, et al.
The Journal of Experimental Medicine|October 2, 2013
Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemiaLena Harder, Georg Eschenburg, Antonia Zech, et al.
Haematologica|June 6, 2020
Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemiaMarketa Zaliova, Eliska Potuckova, Julius Lukes, et al.
Leukemia|October 16, 2019
Treatment and outcome of IG-MYC<sup>+</sup> neoplasms with precursor B-cell phenotype in childhood and adolescenceHeidi Herbrueggen, Stephanie Mueller, Jonas Rohde, et al.
Therapeutic Drug Monitoring|December 7, 2017
Therapeutic Drug Monitoring of Asparaginase Activity-Method Comparison of MAAT and AHA Test Used in the International AIEOP-BFM ALL 2009 TrialClaudia Lanvers-Kaminsky, Andrea Rüffer, Gudrun Würthwein, et al.
Leukemia|June 6, 2024
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, et al.
HNO|January 12, 2024
Combination of nivolumab with standard induction chemotherapy in children and adults with EBV-positive nasopharyngeal carcinoma : Protocol of a prospective multicenter phase 2 trialTristan Römer, Christian Vokuhl, Gundula Staatz, et al.
Pageof 28